These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
450 related articles for article (PubMed ID: 24023385)
21. An infectious cDNA clone of a growth attenuated Korean isolate of MERS coronavirus KNIH002 in clade B. Kim M; Cho H; Lee SH; Park WJ; Kim JM; Moon JS; Kim GW; Lee W; Jung HG; Yang JS; Choi JH; Lee JY; Kim SS; Oh JW Emerg Microbes Infect; 2020 Dec; 9(1):2714-2726. PubMed ID: 33295839 [TBL] [Abstract][Full Text] [Related]
22. One for all-human kidney Caki-1 cells are highly susceptible to infection with corona- and other respiratory viruses. Daniels A; Fletcher S; Kerr HEM; Kratzel A; Pinto RM; Kriplani N; Craig N; Hastie CJ; Davies P; Digard P; Thiel V; Tait-Burkard C J Virol; 2023 Sep; 97(9):e0055523. PubMed ID: 37668370 [No Abstract] [Full Text] [Related]
23. Rescue of SARS-CoV-2 from a Single Bacterial Artificial Chromosome. Ye C; Chiem K; Park JG; Oladunni F; Platt RN; Anderson T; Almazan F; de la Torre JC; Martinez-Sobrido L mBio; 2020 Sep; 11(5):. PubMed ID: 32978313 [TBL] [Abstract][Full Text] [Related]
24. Antagonism of dsRNA-Induced Innate Immune Pathways by NS4a and NS4b Accessory Proteins during MERS Coronavirus Infection. Comar CE; Goldstein SA; Li Y; Yount B; Baric RS; Weiss SR mBio; 2019 Mar; 10(2):. PubMed ID: 30914508 [TBL] [Abstract][Full Text] [Related]
25. Proteolytic processing, deubiquitinase and interferon antagonist activities of Middle East respiratory syndrome coronavirus papain-like protease. Yang X; Chen X; Bian G; Tu J; Xing Y; Wang Y; Chen Z J Gen Virol; 2014 Mar; 95(Pt 3):614-626. PubMed ID: 24362959 [TBL] [Abstract][Full Text] [Related]
26. Cross-Protection against MERS-CoV by Prime-Boost Vaccination Using Viral Spike DNA and Protein. Choi JA; Goo J; Yang E; Jung DI; Lee S; Rho S; Jeong Y; Park YS; Park H; Moon YH; Park U; Seo SH; Lee H; Lee JM; Cho NH; Song M; Kim JO J Virol; 2020 Nov; 94(24):. PubMed ID: 32967955 [TBL] [Abstract][Full Text] [Related]
35. The recombinant N-terminal domain of spike proteins is a potential vaccine against Middle East respiratory syndrome coronavirus (MERS-CoV) infection. Jiaming L; Yanfeng Y; Yao D; Yawei H; Linlin B; Baoying H; Jinghua Y; Gao GF; Chuan Q; Wenjie T Vaccine; 2017 Jan; 35(1):10-18. PubMed ID: 27899228 [TBL] [Abstract][Full Text] [Related]
36. Single Amino Acid Substitution in the Receptor Binding Domain of Spike Protein Is Sufficient To Convert the Neutralization Profile between Ethiopian and Middle Eastern Isolates of Middle East Respiratory Coronavirus. Sugimoto S; Kakizaki M; Kawase M; Kawachi K; Ujike M; Kamitani W; Sentsui H; Shirato K Microbiol Spectr; 2023 Feb; 11(2):e0459022. PubMed ID: 36744940 [TBL] [Abstract][Full Text] [Related]
37. Immunogenicity of Candidate MERS-CoV DNA Vaccines Based on the Spike Protein. Al-Amri SS; Abbas AT; Siddiq LA; Alghamdi A; Sanki MA; Al-Muhanna MK; Alhabbab RY; Azhar EI; Li X; Hashem AM Sci Rep; 2017 Mar; 7():44875. PubMed ID: 28332568 [TBL] [Abstract][Full Text] [Related]
38. MERS coronavirus nsp1 participates in an efficient propagation through a specific interaction with viral RNA. Terada Y; Kawachi K; Matsuura Y; Kamitani W Virology; 2017 Nov; 511():95-105. PubMed ID: 28843094 [TBL] [Abstract][Full Text] [Related]
39. Replication of Severe Acute Respiratory Syndrome Coronavirus 2 in Human Respiratory Epithelium. Milewska A; Kula-Pacurar A; Wadas J; Suder A; Szczepanski A; Dabrowska A; Owczarek K; Marcello A; Ochman M; Stacel T; Rajfur Z; Sanak M; Labaj P; Branicki W; Pyrc K J Virol; 2020 Jul; 94(15):. PubMed ID: 32434888 [TBL] [Abstract][Full Text] [Related]
40. From SARS to MERS: 10 years of research on highly pathogenic human coronaviruses. Hilgenfeld R; Peiris M Antiviral Res; 2013 Oct; 100(1):286-95. PubMed ID: 24012996 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]